41,282,770 doses of Covid-19 vaccines by the end of September 2021.
Nigeria to receive additional 41 million COVID-19 vaccine in September
The expected dose is a combination of the Oxford-AstraZeneca vaccines, Pfizer-Bio-N Tech/Moderna and Johnson & Johnson (J&J) Covid-19.
The Executive Director of the National Primary Health Care Development Agency (NPHCDA) Dr. Faisal Shuaib made the disclosure at a briefing in Abuja.
Dr Shuaib said that
“the AstraZeneca and Pfizer Covid-19 vaccines are expected through the Covid-19 Vaccines Global Assess Facility (COVAX) while the Jassen vaccines are expected from the African Union Commission.’’
“We have received communication for the delivery of the following vaccine shipments in the coming months. 3,924,000 doses of Oxford/AstraZeneca/Moderna by end of July or early August 2021 from the COVAX facility. 3,930,910 doses of Pfizer-Bio-N Tech/Moderna Covid-19 vaccine in August from the COVAX facility donated by the United States Go
Nigeria
United-states
Abuja
Abuja-federal-capital-territory
London
City-of
United-kingdom
Nigerian
Johnson-jassen
Faisal-shuaib
Oxford-astrazeneca-moderna
Moderna-covid